PMID: 377166Jul 1, 1979Paper

Gracilis myocutaneous flap in reconstruction of the vulva and female perineum

Obstetrics and Gynecology
C R WheelessG P Maxwell

Abstract

For the past 2 decades there has been a definite trend among pelvic surgeons to immediately reconstruct the large defects created by deforming radical cancer surgery in the female pelvis and perineum. Extensive en bloc removal of more tissue has enhanced the probabilities of increased 5-year survival. At the same time, however, the quality of life following radical surgery has been of great concern to both patient and surgeon. Recent advances have been made in techniques for reconstruction. It is the purpose of this paper to present our experience using the gracilis myocutaneous flap for reconstruction of the vulva after radical excision of perineal tissue. The technique of the procedure is presented with the clinical results in 5 cases, and the complications noted therein.

Citations

Jan 1, 1993·Surgical and Radiologic Anatomy : SRA·M JuricicS Juskiewenski
Nov 4, 2008·Archives of Gynecology and Obstetrics·Christl ReisenauerDiethelm Wallwiener
Sep 11, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·Kalyan K Dhar, Robert P Woolas
Jan 10, 1998·American Journal of Obstetrics and Gynecology·R Reid
Feb 7, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S M Eisenkop, N M Spirtos
Jan 1, 1982·The British Journal of Surgery·S L Blamey, P W Lee
Feb 1, 1983·The British Journal of Surgery·B P Waxman
Nov 1, 1987·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M J Webb, E W Weaver
Nov 1, 1990·British Journal of Obstetrics and Gynaecology·J H ShepherdN Breach
Nov 1, 1989·Diseases of the Colon and Rectum·T B JulianN Wolmark

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.